BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Prostate cancer

1. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [